Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

Teva Pharmaceuticals USA Recalls Several Lots of Zeosa
Teva Pharmaceuticals USA has recalled several lots of the birth control pills Zeosa (norethindrone and ethinyl estradiol tablets 0.4 mg/0.035 mg, and ferrous fumarate tablets 75 mg). The following lot numbers have been recalled because routine testing found that tablets in these lots may contain impurities: 33800226A, 33800333A, 33800870A, 33802533A, and 33802720A. Zeosa contains the active ingredient norethindrone, ethinyl estradiol, and ferrous fumarate and is commonly used in the prevention of pregnancy. This recall alert only applies to the select lot of Zeosa (norethindrone and ethinyl estradiol tablets 0.4 mg/0.035 mg, and ferrous fumarate tablets 75 mg). No other norethindrone, ethinyl estradiol and ferrous fumarate products were involved in this recall. To view the FDA notice about this recall, please visit: http://www.fda.gov/Safety/Recalls/EnforcementReports/ucm308307.htm
Learn More

Teva Pharmaceuticals USA, Inc. Recalls Several Lots of Atenolol Tablets, 25 mg
Teva Pharmaceuticals USA, Inc. has recalled several lots of Atenolol Tablets, 25 mg. The following lot numbers have been recalled because some lots may contain very small pieces of stainless steel: 90A024, 90A026, and 90A028. Atenolol is used in the treatment of high blood pressure. This recall alert only applies to the single lot of the generic Atenolol Tablets, 25 mg made by Teva Pharmaceuticals USA, Inc. No other Atenolol products were involved in this recall. To view the FDA notice about this recall, please visit: http://www.fda.gov/Safety/Recalls/EnforcementReports/ucm308307.htm
Learn More

Receive Safety Alerts & Recalls by email or text message.

Register

Date Published Title Drug Source
2012-07-23 Teva Pharmaceuticals USA Recalls Several Lots of Zeosa Norethindrone / Ethinyl Estradiol / Ferrous Fumarate FDA
2012-07-23 Teva Pharmaceuticals USA, Inc. Recalls Several Lots of Atenolol Tablets, 25 mg Atenolol FDA
2012-07-22 Physicians Total Care, Inc Recalls Several Lots of Arthrotec 75 Diclofenac Sodium with Misoprostol FDA
2012-07-22 Bausch & Lomb, Inc. Recalls Several Lots of Murocel Lubricant Eye Drops Methylcellulose FDA
2012-07-22 Noven Pharmaceutical Recalls Several Lots of Daytrana Patches Methylphenidate FDA
2012-07-22 Endo Pharmaceuticals Recalls One Lot of Endocet Tablets, 10 mg/650 mg Acetaminophen with Oxycodone FDA
2012-07-22 Dermallogix Partners Recalls Single Lot of DermaZinc Spray, 0.25% zinc pyritione Dermazinc FDA
2012-07-20 Mylan Pharmaceuticals Inc Recalls Single Lot of Alprazolam Extended-release Tablets, 2 mg Alprazolam FDA
2012-07-20 Ortho-McNeil-Janssen Pharmaceuticals, Inc. Recalls Single Lot of Duragesic 25 mcg/h Fentanyl FDA
2012-07-20 Mallinckrodt Inc. Recalls Several Lots of Methylin Chewable Tablets (methylphenidate HCl) 2.5 mg, 5 mg and 10 mg Methylphenidate FDA
2012-07-19 Shionogi Inc. Recalls Single Lot of Nisoldipine Extended Release Tablets, 17mg Nisoldipine FDA
2012-07-19 Teva Pharmaceuticals Recalls Single Lot of Mefloquine Tablets, 250 mg Mefloquine FDA
2012-07-19 Lloyd Pharmaceutical Recalls Select Lots of Levothroid 50 mcg and 75 mcg Tablets Levothyroxine FDA
2012-07-19 Watson Laboratories Recalls Several Lots of Loxapine Capsules Loxapine FDA
2012-07-19 Ranbaxy Recalls Single Lot of Balnetar Therapeutic Tar Bath, Coal Tar 2.5% FDA
2012-07-19 TEVA Phamaceuticals Recalls Single Lot of Metoprolol Tartrate Tablets 50 mg Metoprolol FDA
2012-07-10 FDA Approves Safety Program to Reduce Risk of Opioid Pain Relievers Oxymorphone FDA
2012-07-10 FDA Approves Safety Program to Reduce Risk of Opioid Pain Relievers Methadone FDA
2012-07-05 Physicians Total Care Recalls Several Lots of Lipitor (Atorvastatin calcium) 40 mg Atorvastatin FDA
2012-07-05 Teva Pharmaceuticals Recalls Several Lots of Jolessa 0.15 mg/0.03 mg Levonorgestrel with Ethinylestradiol FDA